Company-wide revenue
Reported revenue in 2020 ¥36.22B Reported revenue in 2024 ¥34.44B
- growth amount
- −¥1.78B
- growth annualized
- -1.3%
- growth total
- -4.9%
Japanese company profile · 7446
TOHOKU CHEMICAL CO., LTD.
In its FY2024 public filing, TOHOKU CHEMICAL CO., LTD. reports Industry, Medical Services, Academy of Life Sciences. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 東北化学薬品株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
TOHOKU CHEMICAL CO., LTD.'s largest reported business by revenue in FY2024 was Industry.
FY2024 · fiscal year ended September 2025 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Industry | ¥17.86B ↗ | 51.9% | — |
| Medical Services | ¥14.14B ↗ | 41.1% | — |
| Academy of Life Sciences | ¥2.44B ↗ | 7.1% | — |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2024 · fiscal year ended September 2025. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Industry
- インダストリー
- Medical Services
- メディカル
- Academy of Life Sciences
- アカデミア・ライフサイエンス
- Business label unavailable in English
- 化学工業薬品
- Business label unavailable in English
- 臨床検査試薬
- Food Products
- 食品
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Industry
- インダストリー
- Medical Services
- メディカル
- Academy of Life Sciences
- アカデミア・ライフサイエンス
- Business label unavailable in English
- 化学工業薬品
- Business label unavailable in English
- 臨床検査試薬
- Food Products
- 食品
- Sales
- 売上高
- Operating profit
- 営業利益
What is growing?
What is growing?
Business revenue growth
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2024 · fiscal year ended September 2025
The source document may be in Japanese.
Filing ID: S100XAMG
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.